New Guideline on Hyperphosphatemia Management in Patients with Severe CKD.

United Kingdom's National Institute for Health and Clinical Excellence has published a new clinical guideline on hyperphospatemia management in patients with stages 4 and 5 CKD. It advises that a specialist renal dietitian should assess and give individualized information on managing dietary phosphate. For adults, calcium acetate should be offered as first-line treatment to control serum phosphate in addition to dietary management; for children, a calcium-based phosphate binder should be offered. At every routine clinical review, physicians should assess patients' serum phosphate control, taking into account dietary phosphate management, phosphate binder regimen, and treatment adherence.